​

Dr. Reddy's Laboratories (RDY) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

RDY Stock Forecast

Dr. Reddy's Laboratories (RDY) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $14.35, with a high of $14.80 and a low of $13.90. This represents a 8.63% increase from the last price of $13.21.

High: $14.8 Avg: $14.35 Low: $13.9 Last Closed Price: $13.21

RDY Stock Rating

Dr. Reddy's Laboratories stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (50.00%), 4 Hold (33.33%), 2 Sell (16.67%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 2 4 6 Strong Sell Sell Hold Buy Strong Buy

RDY Price Target Upside V Benchmarks

TypeNameUpside
StockDr. Reddy's Laboratories8.63%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.48%

Price Target Trends

1M3M12M
# Anlaysts222
Avg Price Target$14.35$14.35$14.35
Last Closing Price$13.21$13.21$13.21
Upside/Downside8.63%8.63%8.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26-221-5
Sep, 26-221-5
Aug, 26-221-5
Jul, 26-221-5
Jun, 26-221-5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 25, 2026Jefferies$13.90$13.215.22%5.22%
Oct 12, 2026Tausif ShaikhBNP Paribas$14.80$12.4818.59%12.04%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 25, 2026JefferiesHoldupgrade
Oct 12, 2026Exane BNP ParibasOutperformupgrade
Sep 29, 2026CitigroupBuyupgrade
Apr 23, 2026Goldman SachsSelldowngrade
Dec 19, 2024NomuraNeutraldowngrade
Jul 30, 2024BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $70 $140 $210 $280 $350 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$142.08$271.47$334.02----
Avg Forecast$171.79$47.23$64.18$67.09$69.16$61.39$68.09
High Forecast$190.85$49.57$64.67$68.77$74.16$64.43$71.46
Low Forecast$151.29$44.88$64.02$63.73$64.99$58.33$64.70
Surprise %-17.29%474.78%420.44%----

Revenue Forecast

$150B $220B $290B $360B $430B $500B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$214.39B$245.88B$279.16B----
Avg Forecast$212.60B$242.04B$277.32B$320.55B$348.92B$346.78B$446.72B
High Forecast$230.75B$251.26B$287.88B$324.86B$364.98B$359.99B$463.74B
Low Forecast$193.08B$232.77B$276.49B$315.38B$338.21B$333.50B$429.61B
Surprise %0.84%1.59%0.67%----

Net Income Forecast

$0 $400B $800B $1T $2T $2T Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$23.57B$45.07B$55.68B----
Avg Forecast$28.64B$39.37B$1.65T$55.92B$57.65B$51.17B$56.75B
High Forecast$31.82B$41.32B$1.98T$57.32B$61.81B$53.70B$59.56B
Low Forecast$25.22B$37.41B$1.32T$53.12B$54.17B$48.62B$53.93B
Surprise %-17.71%14.47%-96.62%----

RDY Forecast FAQ

Is Dr. Reddy's Laboratories stock a buy?

Dr. Reddy's Laboratories stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 4 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Dr. Reddy's Laboratories is a favorable investment for most analysts.

What is Dr. Reddy's Laboratories's price target?

Dr. Reddy's Laboratories's price target, set by 12 Wall Street analysts, averages $14.35 over the next 12 months. The price target range spans from $13.9 at the low end to $14.8 at the high end, suggesting a potential 8.63% change from the previous closing price of $13.21.

How does Dr. Reddy's Laboratories stock forecast compare to its benchmarks?

Dr. Reddy's Laboratories's stock forecast shows a 8.63% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (22.48%).

What is the breakdown of analyst ratings for Dr. Reddy's Laboratories over the past three months?

  • October 2026: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 20.00% Sell, 0% Strong Sell.
  • September 2026: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 20.00% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 20.00% Sell, 0% Strong Sell.

What is Dr. Reddy's Laboratories’s EPS forecast?

Dr. Reddy's Laboratories's average annual EPS forecast for its fiscal year ending in March 2025 is $67.09, marking a -79.91% decrease from the reported $334.02 in 2024. Estimates for the following years are $69.16 in 2026, $61.39 in 2027, and $68.09 in 2028.

What is Dr. Reddy's Laboratories’s revenue forecast?

Dr. Reddy's Laboratories's average annual revenue forecast for its fiscal year ending in March 2025 is $320.55B, reflecting a 14.83% increase from the reported $279.16B in 2024. The forecast for 2026 is $348.92B, followed by $346.78B for 2027, and $446.72B for 2028.

What is Dr. Reddy's Laboratories’s net income forecast?

Dr. Reddy's Laboratories's net income forecast for the fiscal year ending in March 2025 stands at $55.92B, representing an 0.42% increase from the reported $55.68B in 2024. Projections indicate $57.65B in 2026, $51.17B in 2027, and $56.75B in 2028.